4-METHYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER, 95.0%, 500mg

2-(5-Chloro-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 3.00 µm, 1 Piece(s)

5-[2-(4-methoxyphenyl)ethyl]-5-methylimidazolidine-2,4-dione, 97%, 100mg

(R)-1-(5-Methylthiophen-2-yl)ethan-1-ol, 98%, 2.5g

Nonane [Standard Material for GC]>99.5%(GC)5mL

tert-Butyl 2-amino-6,7-dihydrothiazolo[5,4-b]pyridine-4(5H)-carboxylate, 95.0%, 1g

Methyl 5-methylpiperidine-3-carboxylate hydrochloride, 95.0%, 5g

Dipropyl Sulfone>99.0%(GC)25g

(1S,2R)-2-METHOXYCARBONYL-CYCLOBUTANE-1-CARBOXYLIC ACID, 95%, 250mg

3-(5-Nitrofuran-2-yl)acrylic acid, 95.0%, 5g

1,1'-Carbonyldiimidazole (CDI), PEPTIPURE® min. 98%, 10 g, glass packaging

2-(4-Chlorophenyl)-6-nitro-1H-1,3-benzodiazole, 98+%, 25mg